BHC

Bausch Health Companies Inc. NYSE

Healthcare ·Drug Manufacturers - Specialty & Generic ·CA · bauschhealth.com

$5.53

Mkt Cap $2.1B

52w Low $4.41 26.2% of range 52w High $8.69

50d MA $5.50 200d MA $6.37

P/E (TTM) 13.8x

EV/EBITDA 7.3x

P/B 5.6x

Debt/Equity -38.4x

ROE -28.3%

P/FCF 2.6x

RSI (14) —

ATR (14) —

Beta 0.40

50d MA $5.50

200d MA $6.37

Avg Volume 1.9M

About

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bau…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 29, 2026	AMC	0.81	0.78	-3.7%	5.59	+4.7%	+2.3%	+1.1%	—	—	—	—	—
Feb 18, 2026	AMC	1.21	1.08	-10.7%	6.19	-7.8%	-4.2%	-1.0%	-3.4%	-2.7%	-1.3%	-19.1%	—
Oct 29, 2025	AMC	1.07	1.16	+8.4%	5.90	+6.8%	+12.0%	+19.0%	+15.4%	+14.2%	+14.9%	+7.6%	—
Jul 30, 2025	AMC	0.97	0.90	-7.2%	6.39	-9.7%	-7.8%	-10.6%	-9.5%	-7.0%	-9.9%	+16.1%	—
Apr 30, 2025	AMC	0.83	0.59	-28.9%	5.30	-1.9%	+0.0%	+2.3%	-7.0%	-10.6%	-11.3%	-14.5%	—
Feb 19, 2025	AMC	1.65	1.15	-30.3%	6.51	+6.9%	+10.3%	+12.3%	+10.1%	+15.8%	+18.3%	+10.0%	—
Oct 30, 2024	AMC	1.03	1.12	+8.7%	8.17	+3.7%	+12.6%	+19.7%	+13.3%	+18.6%	+16.3%	+2.4%	—
Aug 1, 2024	AMC	0.88	0.89	+1.1%	6.10	-10.7%	-7.7%	-14.3%	-11.6%	-14.4%	-10.2%	-0.5%	—
May 2, 2024	AMC	0.75	0.59	-21.3%	8.09	+0.1%	-3.3%	-7.0%	-8.4%	-13.1%	-14.1%	-21.8%	—
Feb 22, 2024	AMC	1.01	1.15	+13.9%	9.30	+0.5%	-1.3%	-3.3%	-1.3%	-1.1%	+1.0%	+1.9%	—
Nov 2, 2023	AMC	0.92	1.03	+12.0%	7.34	+1.1%	+3.1%	+1.5%	-1.2%	-2.3%	-6.8%	+1.9%	—
Aug 3, 2023	AMC	0.75	0.81	+8.0%	9.41	+1.2%	-3.7%	-6.2%	-5.4%	-8.4%	-10.6%	-11.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 27	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$5.63	$5.62	-0.2%	-0.9%	+0.7%	-0.7%	+1.6%	+0.4%
Feb 25	Barclays	Maintains	Equal Weight → Equal Weight	—	$6.02	$6.10	+1.3%	+1.5%	+0.3%	-1.5%	-1.2%	-4.8%
Jan 7	Truist	Maintains	Hold → Hold	—	$7.63	$7.71	+1.0%	+3.5%	+1.8%	-2.9%	-1.8%	-1.7%
May 2	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$5.30	$5.42	+2.3%	+2.3%	-7.0%	-10.6%	-11.3%	-11.3%
Feb 6	Jefferies	Downgrade	Buy → Hold	—	$7.34	$7.30	-0.5%	-10.9%	-12.1%	-13.9%	-13.2%	-13.4%
Jan 30	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$7.47	$7.50	+0.4%	-0.1%	-0.5%	-2.5%	-2.8%	-1.7%
Nov 1	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$9.20	$9.31	+1.2%	+6.3%	+0.7%	+5.3%	+3.3%	+2.4%
Aug 2	Piper Sandler	Downgrade	Neutral → Underweight	—	$6.10	$5.45	-10.7%	-7.7%	-14.3%	-11.6%	-14.4%	-10.2%
Aug 2	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$6.10	$5.45	-10.7%	-7.7%	-14.3%	-11.6%	-14.4%	-10.2%
Jul 25	Truist	Maintains	Hold → Hold	—	$5.81	$5.77	-0.7%	+1.2%	+3.1%	+2.4%	+2.6%	+3.8%
Apr 23	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$8.45	$8.50	+0.6%	+0.9%	+1.3%	+2.0%	+3.1%	+5.1%
Apr 12	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$8.97	$8.84	-1.4%	-2.3%	-3.8%	-2.6%	-3.5%	-4.1%
Apr 5	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$10.05	$10.07	+0.2%	+3.6%	-3.6%	-7.9%	-11.2%	-10.7%
Feb 23	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$9.30	$9.35	+0.5%	-1.3%	-3.3%	-1.3%	-1.1%	+1.0%
Sep 20	Jefferies	Upgrade	Hold → Buy	—	$7.72	$8.68	+12.4%	+8.0%	+8.7%	+6.5%	+6.9%	+6.6%
Jun 16	TD Cowen	Downgrade	Outperform → Market Perform	—	$7.44	$7.24	-2.7%	-1.2%	-0.5%	-0.9%	-1.5%	-3.4%
May 22	Jefferies	Maintains	Buy → Buy	—	$8.30	$8.46	+1.9%	+6.0%	+1.3%	-0.2%	-1.2%	-1.9%
May 5	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$5.89	$5.96	+1.2%	-1.0%	+1.7%	-0.5%	+1.0%	-1.2%
Sep 9	Piper Sandler	Maintains	Neutral → Neutral	—	$6.70	$6.71	+0.1%	+10.4%	+8.4%	+9.9%	+17.2%	+14.0%
Sep 1	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$5.97	$5.76	-3.5%	+10.4%	+8.0%	+8.7%	+16.4%	+12.2%
Aug 10	BMO Capital	Maintains	Market Perform → Market Perform	—	$5.18	$5.32	+2.7%	+9.1%	+19.7%	+16.0%	+21.2%	+22.8%
Aug 10	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$5.18	$5.32	+2.7%	+9.1%	+19.7%	+16.0%	+21.2%	+22.8%
Jul 29	RBC Capital	Downgrade	Outperform → Sector Perform	—	$5.10	$5.11	+0.2%	-9.4%	-10.0%	-10.2%	+2.0%	+0.4%
Jul 29	Truist	Downgrade	Buy → Hold	—	$5.10	$5.11	+0.2%	-9.4%	-10.0%	-10.2%	+2.0%	+0.4%
Jul 29	JP Morgan	Downgrade	Overweight → Neutral	—	$5.10	$5.11	+0.2%	-9.4%	-10.0%	-10.2%	+2.0%	+0.4%
Jul 26	RBC Capital	Maintains	Outperform → Outperform	—	$8.84	$8.76	-0.9%	-1.1%	-1.8%	-42.3%	-47.7%	-48.1%
May 13	RBC Capital	Maintains	Outperform → Outperform	—	$10.45	$10.53	+0.8%	+3.7%	+3.1%	+5.6%	-4.8%	-2.9%
May 9	RBC Capital	Maintains	Outperform → Outperform	—	$16.04	$15.68	-2.2%	-19.6%	-41.4%	-36.8%	-34.9%	-32.4%
Nov 3	RBC Capital	Maintains	Outperform → Outperform	—	$25.87	$25.98	+0.4%	+5.3%	+4.6%	+8.2%	+9.2%	+6.5%
Oct 1	Jefferies	Maintains	Buy → Buy	—	$27.85	$27.94	+0.3%	+2.7%	+0.5%	+0.9%	-0.9%	+0.3%
Jun 3	Jefferies	Maintains	Buy → Buy	—	$31.89	$31.80	-0.3%	-0.6%	-1.8%	-0.8%	-1.9%	-2.0%
Mar 24	BofA Securities	Downgrade	Neutral → Underperform	—	$31.66	$30.55	-3.5%	-3.0%	-1.8%	-2.1%	-3.1%	-2.0%
Mar 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$33.80	$34.01	+0.6%	-1.2%	-1.4%	-2.8%	-2.4%	-2.5%
Feb 26	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$31.28	$31.42	+0.4%	+0.4%	+1.5%	+3.2%	+4.1%	+2.0%
Feb 17	RBC Capital	Upgrade	Sector Perform → Outperform	—	$31.32	$32.00	+2.2%	+2.3%	+0.8%	+1.9%	+1.0%	+0.8%
Jan 15	Jefferies	Maintains	Buy → Buy	—	$26.41	$26.18	-0.9%	-0.2%	+4.2%	+2.3%	+1.0%	+0.9%
Nov 25	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$19.24	$19.08	-0.8%	-0.4%	+1.5%	-3.5%	-3.1%	-1.0%
Nov 5	Piper Sandler	Maintains	Overweight → Overweight	—	$16.81	$17.05	+1.4%	-0.5%	-1.0%	+14.0%	+15.9%	+15.5%
Oct 28	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$17.74	$17.26	-2.7%	-5.5%	-5.0%	-7.0%	-2.3%	-8.2%
Sep 17	BofA Securities	Upgrade	Underperform → Neutral	—	$16.88	$16.94	+0.4%	+3.0%	+1.8%	-2.1%	-5.0%	-6.8%
Aug 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$16.39	$16.74	+2.1%	+3.4%	+3.4%	+5.3%	+3.7%	+3.2%
Aug 19	Piper Sandler	Maintains	Overweight → Overweight	—	$17.33	$17.23	-0.6%	-2.7%	-2.6%	-5.4%	-2.2%	-2.2%
Aug 10	Citigroup	Maintains	Buy → Buy	—	$18.05	$18.33	+1.6%	-1.8%	-2.2%	-3.7%	-4.8%	-3.2%
Jul 7	BofA Securities	Maintains	Underperform → Underperform	—	$19.00	$18.71	-1.5%	-3.0%	-7.6%	-9.7%	-9.5%	-8.4%
Jun 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$19.38	$20.00	+3.2%	+2.2%	+3.6%	+1.0%	+1.3%	+1.0%
May 8	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$15.87	$15.81	-0.4%	+5.9%	+6.4%	+8.1%	+3.2%	+0.5%
May 8	CFRA	Maintains	Hold → Hold	—	$15.87	$15.81	-0.4%	+5.9%	+6.4%	+8.1%	+3.2%	+0.5%
May 8	SunTrust Robinson Humphrey	Maintains	Buy → Buy	—	$15.87	$15.81	-0.4%	+5.9%	+6.4%	+8.1%	+3.2%	+0.5%
Apr 30	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$18.39	$18.15	-1.3%	-1.5%	-6.7%	-9.3%	-8.8%	-6.9%
Apr 28	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$18.11	$18.65	+3.0%	-3.3%	+1.5%	+0.1%	-5.2%	-7.9%

Recent Filings

8-K · 5.02 !!! Very High

Bausch Health Companies Inc -- 8-K 5.02: Executive Change

Bausch Health amended an executive's 2023 performance stock unit award, affecting 1.14 million PSUs originally scheduled to vest in March 2026, likely reflecting recent leadership changes or compensation restructuring.

Mar 2

8-K

Bausch Health Companies Inc -- 8-K Filing

Bausch Health Companies achieved eleven consecutive quarters of year-over-year revenue and adjusted EBITDA growth excluding Bausch + Lomb, demonstrating sustained operational improvement for investors.

Feb 18

Data updated apr 24, 2026 9:30pm · Source: massive.com